can glp 1 damage kidneys Design and discovery of a highly potent ultralong-acting GLP-1 and glucagon co-agonist for attenuating renal fibrosis Unlocking Cardio-Renal Protection: Breakthrough with

Schrier, R

Interestingly, although the great majority of samples originating from insulinoma cases had GLP1R-expressing acini, the percentage of cases with positively immunostained acini was lower in samples originating from chronic pancreatitis or ductal pancreatic carcinoma (Table 2)

What the research community is saying The research and clinical community has responded to retatrutide data with cautious excitement

Biological Activity Cagrilintide and semaglutide, when co-administered, produce synergistic reductions in bodyweight (up to ~1517% over 2032 weeks in clinical trials) and significant improvements in glycemic parameters, including HbA1c and fasting glucose

10, 2022 from Kim, J